Targeting human serum fucome by an integrated liquid-phase multicolumn platform operating in "cascade" to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera

Proteomics

Volumn 13, Issue 10-11, 2013, Pages 1701-1713

  Selvaraju, Subhashini ^a   Rassi, Ziad El ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Affinity chromatography; Breast cancer; Differential protein expression; Glycoproteomics; Multidimensional LC

Indexed keywords

AGGLUTININ; ALBUMIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; CD5 ANTIGEN; CERULOPLASMIN; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C5; DESMOPLAKIN; FETUIN A; FUCOSE; HEMOPEXIN; IMMUNOGLOBULIN; INTER ALPHA TRYPSIN INHIBITOR; LACTOFERRIN; LECTIN; PHOSPHATIDYLINOSITOL; PLASMA KALLIKREIN; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; PROTHROMBIN; SERUM AMYLOID A;

AFFINITY CHROMATOGRAPHY; ALEURIA AURANTIA; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FUCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LOTUS; LOTUS TETRAGONOLOBUS; MASS SPECTROMETRY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SWITCHING VALVE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; FEMALE; FUCOSE; GLYCOPROTEINS; HUMANS; LECTINS; PROTEOME; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

ALEURIA AURANTIA; LOTUS TETRAGONOLOBUS;

EID: 84878652249     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200524     Document Type: Article

References (39)

1. Apweiler, R., Hermjakob, H., Sharon, N., On the frequency of protein glycosylation as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473, 4-8.
2. van den Steen, P., Rudd, P. M., Dwek, R. A., Opdenakker, G., Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 1998, 33, 151-208.
3. Rademacher, T. W., Parekh, R. B., Dwek, R. A., Glycobiology. Ann. Rev. Biochem. 1988, 57, 785-838.
4. Dube, D. H., Bertozzi, C. R., Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488.
5. Fuster, M. M., Esko, J. D., The sweet and sour cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 2005, 5, 526-542.
6. Drake, P. M., Cho, W., Li, B., Prakobphol, A. et al., Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 2010, 56, 223-236.
7. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F. et al., Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. USA 2005, 102, 779-784.
8. Selvaraju, S., El Rassi, Z., Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-an update covering the period 2008-2011. Electrophoresis 2012, 33, 74-88.
9. Selvaraju, S., El Rassi, Z., Tandem lectin affinity chromatography monolithic columns with surface immobilised concanavalin A, wheat germ agglutinin and Ricinus communis agglutinin-I for capturing sub-glycoproteomics from breast cancer and disease-free human sera. J. Sep. Sci. 2012, 35, 1785-1795.
10. Durham, M., Regnier, F. E., Targeted glycoproteomics: serial lectin affinity chromatoraphy in the selection of O-glycosylation sites on proteins from human blood proteome. J. Chromatogr. A 2006, 1132, 165-173.
11. Madera, M., Mann, B., Mechref, Y., Novotny, M. V., Efficacy of glycoproteins enrichment by microscale lectin affinity chromatography. J. Sep. Sci. 2008, 31, 2722-2732.
12. Mann, B., Madera, M., Klouckova, I., Mechref, Y. et al., A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinoma. Electrophoresis 2010, 31, 1833-1841.
13. Qiu, R., Regnier, F. E., Comparative glycoproteomics of N-linked complex-type glycoforms containing sialic acid in human serum. Anal. Chem. 2005, 77, 7225-7231.
14. Schwientek, T., Mandel, U., Roth, U., Müller, S., Hanisch, F.-G., A serial lectin approach to the mucin-type O-glycoproteome of Drosophila melanogaster S2 cells. Proteomics 2007, 7, 3264-3277.
15. Yang, Z., Hancock, W. S., Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr. A 2004, 1053, 79-88.
16. Yang, Z., Hancock, W. S., Monitoring glycosylation pattern changes of glycoproteins using multi-lectin affinity chromatography. J. Chromatogr. A 2005, 1070, 57-64.
17. Yang, Z., Harris, L. E., Palmer-Toy, D. E., Hancock, W. S., Multilectin affinity chromtography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin. Chem. 2006, 52, 1897-1905.
18. Gunasena, D., El Rassi, Z., Hydrophilic diol monolith for the preparation of immuno-sorbents at reduced nonspecific interactions. J. Sep. Sci. 2011, 34, 2097-2105.
19. Kobata, A., Yamashita, K., in: Fukuda, M., Kobata, A. (Eds.), Glycobiology a Practical Approach, IRL Press, Oxford 1993, pp. 103-125.
20. Yan, L., Wilkins, P. P., Alvarez-Manilla, G., Do, S.-I., Smith, D. F., Immobilized lotus tetragonolobus agglutinin binds oligosaccharides containing the Lex determinant. Glycoconjugate J. 1997, 14, 45-55.
21. Jmeian, Y., El Rassi, Z., Tandem affinity monolithic microcolumns with immobilized protein A, protein Ǵ and antibodies for depletion of high abundance proteins from serum samples: integrated micro columns-based fluidic system for simultaneous depletion and tryptic digestion. J. Proteome Res. 2007, 6, 947-954.
22. Jmeian, Y., El Rassi, Z., Multicolumn separation platform for simultaneous depletion and prefractionation prior to 2-DE for facilitating in-depth serum proteomics profiling. J. Proteome Res. 2009, 8, 4592-4603.
23. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
24. Stelzl, U., Worm, U., Lalowski, M., Haenig, C. et al., A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122, 957-968.
25. Stumpf, M. P. H., Throne, T., de Silva, E., Stewart, R. et al., Estimating the size of the human interactome. Proc. Natl. Acad. Sci. USA 2008, 105, 6959-6964.
26. Chao, J., Schmaier, A., Chen, L.-M., Yang, Z., Chao, L., Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J. Lab. Clin. Med. 1996, 127, 612-620.
27. Polanski, M., Anderson, N. L., A list of candidate cancer biomarkers for targeted proteomics. Biomark. Insights 2006, 2, 1-48.
28. Cho, W., Jung, K., Regnier, F. E., Sialylated Lewis x antigen bearing glycoproteins in human plasma. J. Proteome Res. 2010, 9, 5960-5968.
29. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S. et al., A high-confidence human plasma proteome reference set with estimated concentrations in Peptide Atlas. Mol. Cell. Proteomics 2011, 10, 1-14.
30. Jia, W., Lu, Z., Fu, Y., Wang, H. P. et al., A strategy for precise and large scale identification of core fucosylated glycoproteins. Mol. Cell. Proteomics 2009, 8, 913-923.
31. Nilsson, J., Ruetschi, U., Halim, A., Hesse, C. et al., Enrichment of glycopeptides for glycan structure and attachment site identification. Nat. Methods 2009, 6, 809-811.
32. Comunale, M. A., Wang, M., Hafner, J., Krakover, J. et al., Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J. Proteome Res. 2009, 8, 595-602.
33. Abbott, K. L., Aoki, K., Lim, J. M., Porterfield, M. et al., Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res. 2008, 7, 1470-1480.
34. Cho, W., Jung, K., Regnier, F. E., Use of glycan targeting antibodies to identify cancer-associated glycoproteins in plasma of breast cancer patients. Anal. Chem. 2008, 80, 5286-5292.
35. Comunale, M. A., Lowman, M., Long, R. E., Krakover, J. et al., Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 2006, 5, 308-315.
36. Opstal-van Winden, A. W., Krop, E. J., Karedal, M. H., Gast, M. C. et al., Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study. BMC Cancer 2011, 11, 381.
37. Jung, K., Cho, W., Regnier, F. E., Glycoproteomics of plasma based on narrow selectivity lectin affinity chromatography. J. Proteome Res. 2009, 8, 643-650.
38. Qiu, Y., Patwa, T. H., Xu, L., Shedden, K. et al., Plasma Glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J. Proteome Res. 2008, 7, 1693-1703.
39. Zeng, Z., Hincapie, M., Haab, B. B., Hanash, S. et al., The development of an integrated platform to identify breast cancer glycoproteome changes in human serum. J. Chromatogr. A 2010, 1217, 3307-3315.